Consistent with the signal transduction studies, pre-treatment of the ACHN RCC cell line with multiple concentrations of FLLL32 did not adversely affect transcription of the interferon-regulatory factor-1 (IRF1) gene in response to IFN-γ stimulation as determined by Real Time PCR (Figure 6). The gene discussed is IRF1; the disease is renal cell carcinoma.